NHL: Report: Sens D Thomas Chabot (leg) out at least 4 weeks

Date:

Share post:


In his second game after returning from long-term injured reserve, Ottawa Senators defenseman Thomas Chabot suffered a leg injury and will miss a minimum of four weeks, per a TSN report Thursday.

The oft-injured Chabot missed Tuesday’s 6-2 win over the visiting New York Rangers after injuring his leg Saturday in a 2-0 home victory over the Seattle Kraken.

Chabot, 26, is expected to land on long-term injured reserve, per a Postmedia report. He won’t need surgery, but he will be required to miss 10 games and 24 days.

Chabot has four assists in nine games this season.

On Oct. 28, Chabot went on LTIR with a fractured hand and didn’t return until Dec. 1 in a 4-2 loss against the host Columbus Blue Jackets.

Injuries have been a recurring problem for Chabot, who last season missed time with a concussion and an upper-body injury. He broke his right hand in March 2022 and had his 2020-21 season shortened by injuries.

Chabot signed an eight-year, $64 million extension in September 2019 following a 55-point breakout season in 2018-19.

The 18th overall pick by the Senators in the 2015 draft, Chabot has 53 goals and 233 points in 390 career games.

–Field Level Media

spot_img

Related articles

NHL: Rangers G Igor Shesterkin to start vs. Devils

New York Rangers goaltender Igor Shesterkin will start Thursday's game against the visiting New Jersey Devils, coach Peter...

NHL: Jackets place F Sean Monahan (upper body) on injured reserve

The Columbus Blue Jackets placed forward Sean Monahan on injured reserve Thursday because of an upper-body injury sustained...

NHL: Still without star, Wild aim to ‘rise to the occasion’ vs. Avalanche

The Minnesota Wild will be without their best player for the seventh game in a row when they...

NHL: After rare road win, resurgent Blue Jackets welcome Kraken

The Columbus Blue Jackets begin the second half of their season in position to make the Stanley Cup...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.